What does Balestier invest in?
Balestier invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Apps and Information Technology.

Last cheque observed Jul 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietVC firm
2 rounds on record
Mostly Series B and Series C: 100% of its rounds
Every round we can evidence, newest first2 appearances
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
From their own portfolio page (on their website)
2024 Society of2024 Warwick Prize2025 Newman Prize2026 Dublin Literary2026 PEN AwardEnglish PEN AwardHans Christian Andersen AwardsJCB Prize for LiteratureUTS Glenda Adams
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The latest companies Balestier put money into.
Balestier invests most often at Series B and Series C (100% of the rounds on record), in sectors such as Apps and Information Technology.
2 investments on record, 0 of them in the last 12 months. The most recent was in Jul 2018.
Its most recent investments on record: Cagent Vascular (Series B, Jul 2018) and LimFlow (Series C, Apr 2018).
The median round it joins is $23M.
No investments in the last 12 months; the latest was in Jul 2018.
Balestier is a VC firm.
From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it